En Europa, cada año más de 550.000 pacientes son diagnosticados con cáncer de mama, de los cuales el 70% tiene enfermedad de receptores de estrógeno (ER) positivos; más de 147.000 pacientes con cáncer de mama en Europa mueren anualmente a causa de la enfermedad² ORSERDU es el primer…

ABU DHABI, VAE, 21. September 2023 /PRNewswire/ — Die Vereinigten Arabischen Emirate, Gastgeber des bevorstehenden COP28-Klimagipfels, versammelten die Polizeiführung der UN-Friedensoperationen, um die Kapazitäten zu erweitern und den Klimaschutz in den Gebieten zu verbessern, die am…

Todos os anos na Europa, mais de 550.000 pacientes são diagnosticados com câncer de mama, dos quais 70% tem doença positiva¹ para o receptor de estrogênio (ER)-. Mais de 147.000 pacientes com câncer de mama na Europa morrem anualmente da doença² O ORSERDU é o primeiro tratamento…

6 Clinical Posters and a Presentation Including New Results of a 1,447 Patient Study Highlights the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Applications TORONTO and PHILADELPHIA, Sept. 21, 2023 /PRNewswire/ – MolecuLight Inc., the leader in point-of-care…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.